Worsening of endocrine ophthalmopathy after radioiodine therapy in graves' disease?;Verschlechterung einer endokrinen Orbitopathie nach radioiodtherapie bei M. Basedow?

NuklearMedizin

Volumn 37, Issue 7, 1998, Pages 234-238

  Weigand, A ^a   Hinzpeter, B ^a   Schicha, H ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Endocrine ophthalmopathy; Graves' disease; Radioiodine therapy

Indexed keywords

CORTICOSTEROID; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; RADIATION DOSE; RADIOISOTOPE THERAPY; TREATMENT OUTCOME;

EID: 0031758921     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1632340     Document Type: Article

References (24)

1. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda M L, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A. Relation between therapy for hyperthyroidism and the course of Graves' Ophthalmopathy. N Engl J Med 1998; 338: 73-8.
2. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A. Use of Corticosteroids to Prevent Progression of Graves' Ophthalmopathy after Radioiodine Therapy for Hyperthyroidism. N Engl J Med 1989; 321: 1349-52.
3. Barth A, Probst P, Burgi H. Identification of a subgroup of Graves' disease patients at higher risk for severe Ophthalmopathy after radioiodine. J Endocrinol Invest 1991; 14: 209-12.
4. Gorman CA. Radioiodine Therapy does not aggravate Graves' Ophthalmopathy. JCE & M 1995; 80: 340-2.
5. Hall P, Boice JD, Berg G, Bjelkengren G. Leukaemia incidence after iodine-131 exposure. Lancet 1992; 340: 1-4.
6. Kahaly G, Böckmann, Cordes U, Beyer J, Langzeitbeobachtung der endokrinen Ophthalmopathie und retrospektive Beurteilung therapeutischer Maßnahmen. Med Klin 1989; 84: 121-7.
7. Kahaly G, Förster G, Pitz S, Rosler HP, Mann W. Aktuelle interdisziplinäre Diagnostik und Therapie der endokrinen Orbitopathie. Dtsch med Wschr 1997; 122: 27-32.
8. Kung AWC, Yau CC, Cheng A. The Incidence of Ophthalmopathy after Radioiodine Therapy for Graves' Disease. Prognostic Factors and the Role of Methimazole. JCE & M 1994; 79: 542-6.
9. McDougall IR. Editorial: Does radioiodine cause the ophthalmopaty of Graves' Disease? Nuclear Medicine Communications 1993; 14: 79-81.
10. Perros P, Cromble AL, Kendall-Taylor P. Natural History of thyroid associated ophthalmopathy. Clinical Endocrinology 1995; 42: 45-50.
11. Pickardt CR Beeinflussung der endokrinen Ophthalmopathie durch Radioiodtherapie? Akt Endokr Stoffw Sonderheft 1992; 13: 80-1.
12. Pinchera A, Bartalena I, Marcocci C. Radioiodine may be bad for Graves' Ophthalmopathy. but ... JCE & M 1995; 80: 342-4.
13. Reiners C. Radioiodine treatment of Basedow's Disease: Interference and Influence Factors, Risks Estimation. Exp Clin Endocrinol 1991; 97: 275-85.
14. Reinwein D, Röher HD, Emrich D. Therapie der Hyperthyreose, Aktueller Stand Dtsch med Wschr 1993; 118: 1036-43.
15. Schicha H. Nuklearmedizin. Compaktlehrbuch. 2. korr. Aufl. Stuttgart: Schattauer, 1993.
16. Schicha H. Therapeutische Strategien - nuklearmedizmische Aspekte. Internist 1988; 29: 577-9.
17. Soliman M, Kaplan E, Abdel-Latif A, Scherberg N, De Groot LJ. Does Thyroidectomy. Radioactive Iodine Therapy, or Antithyroid Drug Treatment alter reactivity on patient' T Cells to Epitopes of Thyrotropin Receptor in Autimmune Thyroid Diseases? JCE & M 1995; 80: 2312-21.
18. Sridama V, De Groot LJ. Treatment of Graves' Disease and the Course of Ophthalmopathy. The American Journal of Medicine 1989; 87: 70-3.
19. Tallstedt L, Lundell G, Taube A. Graves' ophthalmopathy and tobacco smoking. Acta Endocrinologica 1993; 129: 147-50.
20. Tallstedt L, Lundell G, Torring O, Wallin G, Ljunggren JG, Blomgren H, Taube A. The Thyroid Study Group: Occurrence of Ophthalmopathy after treatment for Graves' Hyperthyroidism. New Engl J Med 1992; 326: 1733-7.
21. Tallstedt L, Lundell G, Torring O, Wallin G. The Thyroid Study Group: Radioiodine therapy of Graves' Disease and Ophthalmopathy. Exp Clin Endocrinol 1994; 102: 37-42.
22. Tallstedt L, Lundell G, Blomgren H, Bring J. Does early administration of thyroxine reduce the development of Graves'ophthalmopathy after radioiodine treatment? Eur f Endocrinol 1994; 130: 494-7.
23. Torring O, Tallstedt L, Wallin G, Lundell G, Ljundggren JG, Taube A, Saaf M, Hamberger B. The Thyroid Study Group: Graves' Hyperthyroidism: Treatment with antithyroid drugs, Surgery, or Radioiodine - a prospective. randomized Study. J Clin Endocrinol Metab 1996; 81: 2986-93.
24. Wartofsky L. Classification of Eye Changes of Graves' Disease. Thyroid 1992; 2: 235-6.